Application 214031
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 2.5MG | No | No |
| 002 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 5MG | No | No |
| 003 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
| 004 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214031-001 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2020-08-04 | |
| A214031-002 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2020-08-04 | |
| A214031-003 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2020-08-04 | |
| A214031-004 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2020-08-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214031-001 | AB |
| A214031-002 | AB |
| A214031-003 | AB |
| A214031-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214031-001 | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2020-08-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A214031-002 | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2020-08-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A214031-003 | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2020-08-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A214031-004 | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2020-08-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214031-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A214031-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A214031-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A214031-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Bryant Ranch Prepack | d8a5cc4b-9d9d-43af-9ee4-57381aa6368a | 2024-05-28 | Warnings, Adverse reactions | 214031 ANDA214031 |
| VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | d2dce236-257e-44b6-93a9-9f0280257c6a | 2023-03-22 | Warnings, Adverse reactions | 214031 ANDA214031 62332-238 62332-239 62332-236 62332-237 |
| VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 9b8da728-8f52-4c1f-9f0c-4bd9736e912f | 2023-01-24 | Warnings, Adverse reactions | 214031 ANDA214031 46708-237 46708-236 46708-239 46708-238 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 46708-236 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-237 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-238 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-239 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Limited | ANDA | Current |
| 62332-236 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-236 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-236 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-237 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-237 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-237 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-238 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-238 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-238 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-239 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-239 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-239 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ANDA | Current |